investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Role of PALB2 in the DNA Damage Response and Cancer Suppression
Bing Xia
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Bing Xia
Rutgers University
New Brunswick, United States
Related projects
Celina G Kleer
The Function of EZH2 in Estrogen Receptor Negative Breast Cancer in Women of Af
Breast
Marcus E Peter
Fas protects cancer stem cells from death
Breast
Aliccia Bollig-Fischer
The Molecular Link from Type 2 Diabetes to Breast Cancer
Breast
David H Haussler
Center for Big Data in Translational Genomics
Breast
Kristina Cotter
Elucidating the Role of Plasma Membrane V-ATPases in Breast Cancer Metastasis
Breast
Pathology
Amato J Giaccia
Tumor Hypoxia: Molecular Studies and Clinical Exploitation
Breast
Radiation Oncology
Philip Tofilon
Radiation-induced translational control of gene expression
Breast
Radiation Oncology
Fraser Symmans
Development of A Predictive Genomic Diagnostic Test for Survival Benefit from Everolimus (mTOR Inhibitor) Combined with Endocrine Therapy for Metastatic HR+/HER- Breast Cancer
Breast
David E Goldgar
A Comprehensive Approach to Breast Cancer Susceptibility Across the Risk Spectrum
Breast